AURORA
  • Home
  • Project
    • Results
    • Resources
  • About us
    • Partner Organizations
    • Team Members
    • CUSP Research Cluster
  • News
  • Events
    • Upcoming events
    • Previous events
  • Contact
Menu
  • Home
  • Project
    • Results
    • Resources
  • About us
    • Partner Organizations
    • Team Members
    • CUSP Research Cluster
  • News
  • Events
    • Upcoming events
    • Previous events
  • Contact

Project

Quick facts

  • Project Name: Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics (AURORA)
  • Focuses on researching early-life human health impacts from exposure to micro- and nanoplastics
  • Funded by the European Union under the Horizon 2020 research and innovation program
  • Started in April 2021 and runs for 5 years
  • Involves 11 partner organizations from 9 different countries
  • Is one of five Horizon 2020 projects within the CUSP research cluster investigating the health impacts of micro- and nanoplastics

AURORA’s 7 objectives

  • Objective 1: develop new, low-throughput METHODS for in-depth characterization of micro- and nanoplastics in complex matrices (e.g. human tissues, foodstuffs, etc.)
  • Objective 2: innovate high-throughput METHODS for use in large scale health studies of diverse human populations
  • Objective 3: assess health EFFECTS in placenta and the developing fetus
  • Objective 4: EPIDEMIOLOGY – study effects of micro- and nanoplastics exposure in human populations (including two birth cohort studies)
  • Objective 5: deliver an actionable roadmap for RISK ASSESSMENT by integrating results from the other objectives
  • Objective 6: COMMUNICATE research findings, make results actionable to stakeholders, support stakeholder dialogue
  • Objective 7: MANAGE the project, coordinate with other CUSP research cluster projects

Background

The scale of micro- and nanoplastic (MNP) pollution is becoming increasingly clear yet little is known about how this pollution impacts health. The team of international researchers within the AURORA project are developing an actionable European roadmap for early-life health risk assessment of MNPs to support better regulation and use of MNPs.

Supported by the EU’s Horizon 2020 research and innovation program, AURORA will focus on better understanding MNP exposures and toxicological and health effects during pregnancy, in utero, and in early life. These periods are critical for development and health later in life. It has been shown that MNPs are likely to cross the placental barrier in vitro and in vivo, underlying the urgent need to understand the impact of MNPs on reproductive and early-life health. AURORA will do this by significantly enhancing exposure assessment capabilities for measuring MNPs and MNP-associated chemicals (e.g. additives) in tissues relevant for early-life development (placenta, cord blood, amniotic fluid, meconium, fetal tissue). It will take a unique approach by combining in-depth characterization and scalable technologies to develop methods for both detailed and large-scale toxicological, exposure assessment, and epidemiological studies.

This will be combined with a novel tiered-testing approach and epidemiological investigations to provide the first extensive evaluation of maternal and fetal MNP exposures and health perturbations, including placental function, immune-inflammatory responses, oxidative stress, accelerated aging, endocrine disruption, and child development. In the course of developing and applying the tools and methodological workflows of the AURORA research program, the project partners will create a risk assessment framework specific to MNPs and identify the remaining knowledge gaps and priorities needed for comprehensively evaluating the impact of MNPs on early-life health. A short introduction video about AURORA is also available.

Researching early life health impacts of micro- and nanoplastic

page-overlay-white

NEWS

Project partners meet and reflect on AURORA’s first year

June 23, 2022

Microplastic impacts on child health: knowns and unknowns

February 16, 2022

Scientific studies evaluate microplastic effects on human cells

January 18, 2022

> Subscribe to our newsletter

Twitter
Linkedin
Youtube
Envelope
EU

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under AURORA grant agreement No 964827.

Webdesign » SPRANQ
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

SAVE & ACCEPT